Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer
Clinical trial NCT00536861 · COMPLETED
Trial details
- NCT number
- NCT00536861
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2007-12-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.